Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessRetraction

Retraction: analysis of the TCR alpha and beta chain CDR3 spectratypes in the peripheral blood of patients with Systemic Lupus Erythematosus

Wei Luo1 email, Li Ma1 email, Qian Wen1 email, Xin-Sheng Yao1 email, Na Wang3 email, Hong-Yun Zou1 email, Ming-Qian Zhou1 email, Ying Lin2 email, Zhen-Qiang Wu2 email, Xiao-Wei He2 email, Ju-Fang Wang2 email and Xiao-Ning Wang1,2 email

1Institute of Molecular Immunology, Southern Medical University, Guangzhou, 510515, PR China

2College of Biosciences & Bioengineering, South China University of Technology, Guangzhou, 510641, PR China

3Department of Dermatology & Rheumatology, Nan fang Hospital, Guangzhou, 510515, PR China

author email corresponding author email

Journal of Autoimmune Diseases 2008, 5:5doi:10.1186/1740-2557-5-5

The electronic version of this article is the complete one and can be found online at: http://www.jautoimdis.com/content/5/1/5

Received: 11 August 2008
Accepted: 11 August 2008
Published: 11 August 2008

© 2008 Luo et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Retraction

BioMed Central is publishing a retraction of this article [1] as it was published in error. BioMed Central apologize to the authors for the error and any inconvenience caused. An apology is also extended to the readers.

References

  1. Luo W, Ma L, Wen Q, Yao X-S, Wang N, Zou H-Y, Zhou M-Q, Lin Y, Wu Z-Q, He X-W, Wang J-F, Wang X-N: Analysis of the TCR alpha and beta chain CDR3 spectratypes in the peripheral blood of patients with Systemic Lupus Erythematosus.

    J Autoimmune Dis 2008, 5:4. PubMed Abstract | BioMed Central Full Text OpenURL

Have something to say? Post a comment on this article!


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.